MARATTO

article · Egyptian Journal of Ophthalmology

Choroidal Neovascularization Post-Alexandrite Laser Hair Removal: OCT Angiography and Intravitreal aflibercept Injection: A Case Study

Abstract

Introduction: Photic retinopathy is a rare condition that typically occurs due to prolonged exposure to intense light sources. This case report presents a unique instance of photic retinopathy resulting from accidental exposure to alexandrite laser. Case presentation: A twenty-year-old female with no prior medical history experienced immediate vision loss in her left eye after unintentional self-exposure to an Alexandrite laser. Diagnostic imaging revealed a yellowish macular spot surrounded by a pigment halo on colored fundus photography, disrupted retinal layers on Optical Coherence Tomography (OCT), and occult choroidal neovascularization on Optical Coherence Tomography-Angiography (OCT-A), indicating significant macular damage. Various treatment strategies were employed to prevent further progression and improve vision.Conclusion: This paper highlights a rare side effect of Alexandrite laser exposure detected using OCT-A. Early diagnosis and management, including intravitreal aflibercept injection, were crucial in achieving favorable visual outcomes. The implementation of specific protective measures is essential for preventing photic retinopathy

Research topics

  • Dermatologic Treatments and Research
  • Laser Applications in Dentistry and Medicine
  • Facial Rejuvenation and Surgery Techniques

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/ejomos.2024.211641.1115

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.